KZIA Financials
Kazia Therapeutics Ltd - Financial statements & key metrics
Stock Price
$11.22
Market Cap
$124.78M
EPS
$-7.58
Income Statement Highlights
Most Recent Quarter: 2025-06-30
Revenue
$42000.00
Gross Profit
$42000.00
Operating Income
$-14.22M
Net Income
$-20.70M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$6.06M
Total Liabilities
$14.36M
Shareholders Equity
$-8.30M
Cash & Equivalents
$4.34M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-13.28M
CapEx
$0
Free Cash Flow
$-13.28M
Profitability Metrics
Gross Margin
100.0%
Operating Margin
-146.4%
ROE
-1.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is KZIA revenue?
KZIA's most recent quarterly revenue was $42000.00. Annual revenue can be calculated by summing the four most recent quarters.
Is KZIA profitable?
KZIA reported a loss of $20.70M in the most recent quarter.
What is KZIA market cap?
KZIA has a market capitalization of $124.78M, making it a small-cap stock.
Does KZIA have debt?
View KZIA's balance sheet for debt information.
What is KZIA cash flow?
KZIA's most recent quarterly free cash flow was $-13.28M.